import json

data = {
 "topic": "Lead Poisoning",
 "slug": "lead-poisoning",
 "category_id": 15528,
 "summary": "Childhood lead poisoning is usually asymptomatic and detected by screening, but can cause microcytic anemia and, at high levels, severe neurologic toxicity including encephalopathy; management is removal from the lead source with chelation reserved for significantly elevated levels.",
 "written_by": "claude-sonnet",
 "references": [
  {"title": "2021_Fleisher_&_Ludwig's_Textbook_of_Pediatric_Emergency_Medicine.epub", "author": None, "pages": []},
  {"title": "Zitelli and Davis' Atlas of Pediatric Physical Diagnosis: Expert Consult - Online", "author": None, "pages": [455]},
  {"title": "Pediatric Environmental Health", "author": "American Academy of Pediatrics Council on Environmental Health,Ruth A. Etzel,Sophie J. Balk", "pages": [597, 599]},
  {"title": "CURRENT Diagnosis and Treatment Pediatrics, Twenty-Fourth Edition", "author": "Hay, William W., Levin, Myron J., Deterding, Robin R., Abzug, Mark J.", "pages": [264]},
  {"title": "The Harriet Lane Handbook (The Johns Hopkins Hospital)", "author": None, "pages": [91]},
  {"title": "The Harriet Lane Handbook 22nd Edition (2020) (The Johns Hopkins Hospital)", "author": None, "pages": [91]},
  {"title": "Pediatric Board Study Guide", "author": None, "pages": [40]},
  {"title": "Signs and Symptoms in Pediatrics", "author": "Henry M. Adam,Jane Meschan Foy", "pages": [79]}
 ],
 "short": [
  {"title": "In short", "content": (
   "- Any measurable blood lead level (BLL) is abnormal, but clinically significant lead poisoning is generally considered to occur above 10 mcg/dL, and levels above 5 mcg/dL deserve attention; BLLs below 10 mcg/dL have still been correlated with lower IQ\n"
   "- Children are especially vulnerable due to hand-to-mouth behavior (mouthing objects, pica) and more efficient gastrointestinal lead absorption than adults\n"
   "- Most children with lead toxicity are asymptomatic, and lead poisoning is typically diagnosed on routine screening rather than from symptoms\n"
   "- The leading source of lead exposure in the US remains lead-based paint (most residential uses banned since 1977); other sources include dust, soil, parental/household occupational exposure (auto repair, smelting, construction, remodeling, plumbing, firing ranges, painting, e-scrap), glazed ceramics, certain herbal/home remedies (e.g., some Ayurvedic medications, litargirio), and jewelry (toys or costume jewelry)\n"
   "- National mean BLL fell dramatically from 16 mcg/dL in 1976 to under 2 mcg/dL in 2008, though considerable regional variation persists and many at-risk children are not currently screened\n"
   "- Anemia from lead poisoning is microcytic and hypochromic (resembling iron deficiency) but with intense basophilic stippling of red cells; lead inhibits iron insertion into the protoporphyrin ring, elevating free erythrocyte protoporphyrin (elevated in both lead poisoning and iron deficiency, so not specific alone)\n"
   "- Symptoms, when present, are often nonspecific: GI complaints (anorexia, constipation, abdominal pain, vomiting) and CNS effects (irritability, lethargy, sleep changes, behavior/coordination changes); lead encephalopathy - with seizures, hypertension, coma, and signs of raised intracranial pressure - is usually associated with BLL above 70 mcg/dL and shows lymphocytic pleocytosis, elevated protein, and increased pressure on CSF exam\n"
   "- Lead encephalopathy is now rare in the US due to screening and early recognition, but clinicians must maintain a high index of suspicion in children with lead exposure plus GI/neurologic symptoms\n"
   "- Treatment centers on removing the child from further lead exposure; routine chelation is NOT indicated for BLL under 45 mcg/dL; symptomatic lead encephalopathy is treated with IM dimercaprol (BAL) followed by IV calcium disodium EDTA plus aggressive supportive care, with PICU admission if encephalopathy is present; asymptomatic patients with very high BLL (especially >100 mcg/dL) are also at significant CNS risk and may need urgent treatment\n"
   "- With successful intervention, BLL falls most in the first 2 months of therapy, then declines more slowly; average children with moderate poisoning (BLL >20 mcg/dL) reach about 50% reduction by 6-12 months, but children with markedly elevated levels may take years to reach the current CDC reference level (3.5 mcg/dL) even with full source elimination - making early screening the best strategy to avoid needing treatment at all"
  )}
 ],
 "long": [
  {"title": "Definition", "content": (
   "Lead poisoning (lead intoxication) results from excessive absorption of environmental lead. Any measurable blood lead level is considered abnormal, though clinically significant lead poisoning is generally defined as a level above 10 mcg/dL, with levels above 5 mcg/dL warranting clinical attention. The developing infant and child are particularly susceptible because of their propensity to place objects in their mouths (including pica behavior) and their more efficient gastrointestinal absorption of lead compared with adults."
  )},
  {"title": "Epidemiology", "content": (
   "The primary source of lead exposure in the United States remains lead-based paint, even though most residential uses have been banned since 1977. National mean blood lead levels have declined substantially, from a mean of 16 mcg/dL in 1976 to less than 2 mcg/dL in 2008, reflecting successful public health interventions. However, considerable regional variation in lead exposure persists across the United States, and a majority of children at risk for lead toxicity are not currently being screened despite CDC recommendations for universal (or targeted, depending on local risk) lead screening."
  )},
  {"title": "Etiology", "content": (
   "Sources of lead exposure include paint chips, household dust, and soil contaminated with historical lead paint or industrial lead; parental or household contact occupational exposure (auto repair, smelting, construction, remodeling, plumbing, firing range/ammunition exposure, painting, and electronic scrap/e-scrap handling); glazed ceramics; certain herbal remedies (for example, some Ayurvedic medications); home remedies including certain antiperspirants/deodorants (litargirio); and jewelry, whether children's toys or adult costume jewelry. The percentage of ingested lead actually absorbed from the gastrointestinal tract depends on particle size, gastric pH, the presence of other material in the gut, and the child's nutritional status - iron deficiency in particular has been associated with increased lead absorption and higher blood lead levels."
  )},
  {"title": "Pathophysiology", "content": (
   "Lead interferes with heme synthesis by inhibiting the insertion of iron into the protoporphyrin ring, leading to accumulation of free erythrocyte protoporphyrin - a finding that can also be elevated in iron deficiency and is therefore not specific to lead poisoning on its own. This mechanism underlies the characteristic microcytic, hypochromic anemia of lead poisoning, which resembles iron-deficiency anemia but is distinguished by the presence of intense basophilic stippling of red blood cells. Beyond its hematologic effects, lead is neurotoxic, and nonhematologic manifestations - particularly neurologic ones - often dominate the clinical picture in more significant poisoning, ranging from vague behavioral and gastrointestinal symptoms to acute encephalopathy with rapid progression to coma and death at very high exposure levels."
  )},
  {"title": "Clinical features", "content": (
   "Most children with lead toxicity are asymptomatic, which is why lead poisoning is typically identified through routine screening rather than presenting complaints. When symptoms occur, they are often nonspecific: gastrointestinal complaints include anorexia, constipation, abdominal pain, and vomiting, while central nervous system involvement can present as irritability, lethargy, changes in sleep pattern, and alterations in behavior and coordination. More severe presentations range along a spectrum from vague malaise to acute encephalopathy. Lead encephalopathy - characterized by seizures, hypertension, coma, and signs of increased intracranial pressure - is usually associated with blood lead levels higher than 70 mcg/dL. Late physical findings in significant lead intoxication can include papilledema, and significant radiographic changes (such as dense metaphyseal lines on long bone films) may also be seen."
  )},
  {"title": "Diagnostics", "content": (
   "Diagnosis is made by measuring blood lead level (BLL), usually identified through routine screening rather than symptom-driven testing, since most affected children are asymptomatic. Supportive but nonspecific laboratory findings include a microcytic, hypochromic anemia with basophilic stippling, and elevated free erythrocyte protoporphyrin (which is also elevated in iron deficiency and therefore not specific alone). When lead encephalopathy is suspected, cerebrospinal fluid examination characteristically shows a lymphocytic pleocytosis, elevated protein level, and increased opening pressure - findings that support the diagnosis alongside the clinical picture of seizures, altered mental status, and signs of raised intracranial pressure."
  )},
  {"title": "Treatment", "content": (
   "The single most important element of lead poisoning treatment is removing the child from further lead exposure. Routine chelation therapy is not indicated for blood lead levels below 45 mcg/dL. Symptomatic patients with lead encephalopathy should be treated with intramuscular dimercaprol (British anti-Lewisite, BAL) followed by intravenous calcium disodium EDTA, in addition to aggressive supportive care, and generally require PICU-level admission. Asymptomatic patients with very high blood lead levels - especially above 100 mcg/dL - are also at significant risk of developing CNS involvement and may require urgent treatment even without overt symptoms. Hospital admission should also be considered when the home environment is not lead-safe, the source of exposure has not been identified, or further lead exposure remains possible, allowing time for decontamination and confirmatory testing (a stat BLL) alongside treatment planning."
  )},
  {"title": "Prevention", "content": (
   "Because lead poisoning is usually asymptomatic and its neurodevelopmental effects can occur even at BLLs below the traditional 10 mcg/dL action threshold, early screening is the single best strategy for avoiding harm, since it identifies exposure before it produces clinically significant or irreversible effects and allows source identification and remediation before further absorption occurs. Ensuring adequate iron nutritional status may also help reduce gastrointestinal lead absorption, given the documented association between iron deficiency and higher blood lead levels."
  )},
  {"title": "Complications", "content": (
   "Numerous neuropsychological deficits have been associated with elevated blood lead levels, and even BLLs below 10 mcg/dL have been correlated with lower intelligence quotients, underscoring that there is no clearly safe threshold. With successful treatment/exposure elimination, the greatest fall in BLL occurs in the first 2 months after intervention begins, after which the rate of decline slows considerably; by 6-12 months after identification, a child with moderate lead poisoning (BLL greater than 20 mcg/dL) will typically have a BLL about 50% lower than at diagnosis. However, children with markedly elevated initial BLLs may take years to reach the current CDC reference level of 3.5 mcg/dL, even when all sources of lead exposure have been eliminated, behavior modified, and nutrition optimized - reinforcing that prevention and early detection are far more effective than treatment after the fact."
  )}
 ],
 "clinical": [
  {"title": "Approach at the bedside", "content": (
   "Because most children with lead toxicity are asymptomatic, rely on screening rather than waiting for symptoms - check a blood lead level in any child with recognized risk factors (older housing with lead paint, relevant parental/household occupational exposure, imported ceramics/jewelry/remedies, pica behavior, or iron deficiency) and follow local/CDC screening recommendations given that a majority of at-risk children nationally are not currently being screened. Any measurable BLL is technically abnormal; treat levels above 10 mcg/dL as clinically significant and levels above 5 mcg/dL as warranting attention and follow-up.\n\nFor a child with an elevated BLL, the essential first step is removing the child from the lead source - identify and remediate the home environment before or alongside any pharmacologic treatment. Do not chelate for BLL under 45 mcg/dL. For BLL at or above that threshold, or for any symptomatic child, arrange hospital admission for full evaluation, decontamination planning, and chelation therapy; escalate to PICU-level care with IM dimercaprol (BAL) followed by IV calcium disodium EDTA plus aggressive supportive care for any child with signs of lead encephalopathy (seizures, altered mental status, signs of raised intracranial pressure) - this is a medical emergency. Treat asymptomatic children with very high BLL (especially over 100 mcg/dL) as being at significant CNS risk and needing urgent treatment even without overt symptoms. After starting treatment, set expectations with families that BLL falls fastest in the first 2 months but that full normalization, especially from a markedly elevated starting point, may take years even with complete source elimination - so continued monitoring and reinforcement of environmental remediation matters well beyond the initial hospitalization."
  )}
 ]
}

with open("/tmp/lead-poisoning.article.json", "w") as f:
    json.dump(data, f, indent=1)
print("written")